Back to search

United Kingdom· GB-APID-45327811000001102

Ranolazine 750mg modified-release tablets

A ranolazine product containing ranolazine, registered in United Kingdom by Zentiva Pharma UK Ltd. The same ATC class is registered in 16 of our 19 countries.

ATC C01EB18

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedRanolazine 750mg modified-release tab…ATCC01EB18REGISTER NO.GB-APID-4532781100000…PACKS LISTED1CHECKEDSeptember 13, 2026

Where it is registered

Ranolazine is registered in 16 of 19 countries.

Countries holding a registration under ATC C01EB18 (ranolazine), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 10 of them publish a price we can compare per daily dose

Ranolazine · ATC C01EB18

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of ranolazine costs, country by country.

Normalised to the WHO defined daily dose (1.5 g), the median price runs from $0.49 in United States to $5.07 in Switzerland — a ×10 gap.

  • 4 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail

Ranolazine · price per daily dose (1.5 g)

USD · FX 28 Sept 2026

  • CH Switzerland$5.07
  • ES Spain$1.58
  • IT Italy$0.87
  • US United States$0.49 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Ranolazine
Manufacturer
Zentiva Pharma UK Ltd
Country
United Kingdom (GB)
ATC code
C01EB18
ATC class
Ranolazine
Defined daily dose
1.5 g, O
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 1

  • gtin
    8594739303089

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

335 interactions on record for ranolazine.

Graded by severity as the source publishes them — 78 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Ranolazine · interactions on record

335 records

  • 78 severe
  • 205 moderate
  • 29 minor
  • 23 info

Most severe, free to view

  • ClotrimazoleA01AB18severe
  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Ranolazine in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ranolazine products

Authorised across Europe · EMA

The same active substance is authorised in 23 EEA countries. Names it is sold under:

  • Austria · Rande, Ranogelan
  • Bulgaria · Равена
  • Cyprus · Ranolazine Accord, Ranolazine Remedica
  • Czechia · Ranolazine Umedica
  • Germany · Halibrell, Labigat
  • Denmark · Labigat
  • Estonia · Halibrell, Ralik
  • Spain · Labigat, Ranolazina Alter
  • France · Ranolazine Micro Labs
  • Greece · Labigat, Lakosun
  • Croatia · Halibrell, Lasokun
  • Ireland · Ranolazine Accord, Ranolazine Clonmel
  • Iceland · Ranexa
  • Italy · Labigat, Ranolazina Accord
  • Liechtenstein · Ranexa
  • Lithuania · Halibrell, Lasokun
  • Latvia · Halibrell, Lasokun
  • Netherlands · Lazela, Ranogelan
  • Norway · Ranexa
  • Poland · Ralik, Ranolazine Aurovitas
  • Portugal · Ranolazina Adamed, Ranolazina Bluepharma
  • Romania · Ranolazina Atb
  • Slovenia · Halibrell, Ranolazin Stada

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f51996e9-1389-4dac-9198-bd59a0ec5b49
GET /v1/drugs/f51996e9-1389-4dac-9198-bd59a0ec5b49?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "45327811000001102",
  "desc": "Ranolazine 750mg modified-release tablets (Zentiva Pharma UK Ltd)",
  "form": "Modified-release tablet",
  "vpid": "15001011000001109",
  "source": "dmd",
  "vtm_id": "777399003",
  "strength": "750 mg",
  "substance": "Ranolazine",
  "ingredient": "Ranolazine",
  "supplier_code": "9043311000001106"
}

See everything about ranolazine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.